SCHOTT expands melting capacities for pharma tubing
SCHOTT is investing a total of €70 million euros in the expansion of its Indian tubing site in Jambusar, Gujarat.
An additional tank furnace is scheduled to go into operation at the beginning of 2023, with a second one the following year. The expansion will create new jobs for around 225 people and is part of a more than $1 billion strategic investment programme by the company through to 2025.
"Against the backdrop of the growth trend in the Indian pharmaceutical business and the pandemic, we want to commit to secure the supply of pharma glass," explains Dr. Patrick Markschläger, Executive Vice President of SCHOTT's Business Unit Tubing.
"The increase of over 30% in the facility's overall Indian production capacity is at the same time a commitment to supporting the government's vision of India becoming a global pharmaceutical hub," adds Pawan Shukla, Managing Director SCHOTT Glass India, during the groundbreaking event at the site.
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT.
With the additional melting tanks and production lines, SCHOTT intends to ensure that this Asian manufacturing hub can adequately supply high-quality pharma glass for both Indian and neighbouring countries.
SCHOTT has also established a solid production base for high-quality borosilicate glass tubing in Jinyun, China as a supply hub for the local market. The €60 million invested in this tubing plant saw construction completed after just 15 months and created 250 new jobs.
Image: Groundbreaking ceremony in Jambusar, India. Image: SCHOTT